Literature DB >> 6687630

Parathyroidectomy in chronic renal failure.

J K Dawborn, D J Brown, M C Douglas, H H Eddey, W F Heale, D P Thomas, J M Xipell.   

Abstract

Parathyroidectomy was carried out in 26 patients over a 14-year period. Excellent results were obtained in patients with severe hyperparathyroidism. Vascular calcification, hypercalcaemia and pruritus did not justify surgery unless associated with unequivocal hyperparathyroidism. 13 patients required intravenous calcium infusion for up to 2 weeks to control post-operative hypocalcaemia. Calcium requirements could be predicted from the pre-operative plasma alkaline phosphatase level. Following operation continued treatment with vitamin D was necessary to prevent hypocalcaemia. Hyperparathyroidism recurred in 1 patient after 8 years and 4 patients developed osteomalacia. Since parathyroid hormone may have toxic effects other than those on bone, maintenance of normal levels should be a long-term objective in the treatment of patients with chronic renal failure. Where large parathyroid glands are present, surgical reduction in gland mass is a logical prelude to long-term suppression of parathyroid hormone with vitamin D and phosphate-binding agents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687630     DOI: 10.1159/000182921

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

Review 1.  Morbidity and mortality of long-term haemodialysis: a review.

Authors:  R Gabriel
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

2.  Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up.

Authors:  Hazim M Sadideen; John D Taylor; David J Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-10-14       Impact factor: 2.370

Review 3.  Mineral and bone disorder after renal transplantation: a review.

Authors:  Hazim Sadideen; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2007-12-18       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.